![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CureVac Gets $85 Million in EU Funding for Vaccine Production
CureVac Gets $85 Million in EU Funding for Vaccine Production
![MoneyinAir.gif](https://www.fdanews.com/ext/resources/test/Device_Images4/MoneyinAir.gif?t=1578528099&width=430)
CureVac has secured $85 million from the European Investment Bank for the development and large-scale production of vaccines, including its mRNA COVID-19 vaccine candidate.
The German drugmaker said the funding will go toward completing its new mRNA production facility in Tübingen, Germany.
CureVac began a phase 1 clinical trial of its COVID-19 vaccine candidate last month.
Upcoming Events
-
21Oct